Statistics
Thermo Fisher Scientific (TMO) Valuation & Key Statistics
Valuation, profitability, balance-sheet health, and risk metrics for TMO, refreshed each market session.
Section freshness
Prices as of Sep 8, 1:24 PM EDT · Fundamentals checked Sep 8, 12:56 PM EDT · Statements Jun 27, 2026
Key metrics at a glance
The numbers most investors check first
Market cap
$224.31B
P/E (TTM)
32.62
Forward P/E
—
FCF yield
3.26%
Return on equity
—
Dividend yield
0.31%
Valuation
- Market cap
- $224.31B
- Enterprise value
- $223.62B
- P/E (TTM)
- 32.62
- Price / sales
- 4.84
- Price / book
- 4.26
- EPS (TTM)
- $18.60
Long-run compounding
20-year CAGR and aggregate price growth.
Adjusted daily closes are annualized over the tracked 20-year window; dividends are not included in this price-only return view.
- 20Y CAGR
- 14.95%
- From earliest tracked adjusted close on September 8, 2006
- Aggregate CAGR
- 11.54%
- 1Y, 3Y, 5Y, 10Y blended CAGR
- First tracked close
- $37.13
- September 8, 2006
- History span
- 20 yrs
- Sep 8, 2006 to Sep 8, 2026 · 5,030 closes
- Latest tracked close
- $602.89
- September 8, 2026
- 20Y high
- $672.34
- December 31, 2021
- 20Y low
- $26.65
- November 21, 2008
- History source
- Long range
- Yahoo Finance
Valuation map
Risk and scale
Less volatile than the market
Pro formula stack
Ratios investors search for after the headline quote.
These are TECHi-computed from overview, income statement, balance sheet, and cash-flow rows when market-data sources expose the ingredients.
- EV / revenue
- 4.83
- Enterprise value / TTM revenue
- FCF yield
- 3.26%
- TTM free cash flow / market cap
- FCF / share
- $19.76
- TTM free cash flow / shares outstanding
- Earnings yield
- 3.07%
- Inverse P/E
- Rule of 40
- 26.29%
- Revenue growth + FCF margin
- ROIC approx.
- 15.67%
- NOPAT / invested capital
- CROIC
- 14.08%
- FCF / invested capital
- TECHi quality score
- 6 / 7
- 7-point profitability, cash, leverage, and trend check
Quality and capital returns
TTM free cash flow / TTM revenue
TTM FCF / TTM net income
TTM revenue / market cap
Balance-sheet and reinvestment reads
0.00 means net cash
Total debt / TTM FCF
Tech-stock reinvestment intensity
Capital intensity of the business
Distress and optionality read
TMO Altman Z-score needs a fuller balance sheet.
TECHi computes a non-financial-company Altman-style score from working capital, retained earnings, EBIT, market value, liabilities, revenue, and assets. It is not a bankruptcy prediction, but it gives pro readers a fast stress screen that most quote pages do not show beside live valuation metrics.
- Net cash / share
- $1.88
- Cash minus debt, per share
- Working capital
- $8.30B
- Current assets minus current liabilities
- Debt growth YoY
- +52.12%
- Latest quarter vs same quarter last year
Valuation read
TMO trades at 32.62× trailing earnings.
A trailing P/E above 30 means the market is paying up for TMO. That premium has to be earned with above-average revenue or earnings growth.
Profitability
- Operating margin
- 17.40%
- Net margin
- 14.47%
- Debt / equity
- 0.06
- Current ratio
- 1.55
- >1 = covers near-term liabilities
- Beta (5Y)
- 0.85
Margin profile
Profitability read
TMO converts 14.5% of revenue into net income.
Margins in the high single-digits to high-teens are the bulk of the index. The differentiated reads here are operating-margin direction (improving = leverage) and ROE — the latter tells you how much equity capital management actually needs.
Per-share & range
- Dividend yield
- 0.31%
- Forward yield
- Payout ratio
- 2.53%
- Dividend per share / EPS — lower leaves more room to grow
- Dividend coverage
- 42.05×
- TTM free cash flow / dividends paid — above 1× is self-funded
- Shares outstanding
- 370.26M
- 52w high
- $647.00
- 52w low
- $435.27
Corporate actions
Stock split history
Adjusted for all historical splits
- Split events
- 0
Reported fundamentals
Company statistics fields
These figures come from the latest issuer filings and live quote-derived formulas.
- Revenue (TTM)
- $46.34B
- TECHi unified data
- Book value
- $142.47
- TECHi unified data
- Revenue / share
- $125.32
- TECHi unified data
- Earnings growth YoY
- 9.35%
- TECHi unified data
- Revenue growth YoY
- 10.49%
- TECHi unified data
- 50-day average
- $572.53
- TECHi unified data
- 200-day average
- $535.58
- TECHi unified data
- Dividend / share
- $0.47
- Yahoo Finance
- Ex-dividend date
- June 15, 2026
- Yahoo Finance
Frequently asked
Common questions.
What is Thermo Fisher Scientific's market capitalization?
Thermo Fisher Scientific (TMO) has a market capitalization of $224.3 billion.
What is TMO's P/E ratio?
TMO trades at a trailing price-to-earnings ratio of 32.62.
Where do TECHi's TMO statistics come from?
TMO statistics combine exchange quotes with company filings through TECHi's market-data providers. Any figure that is missing or out of date is left blank rather than estimated.